Richard Hantke

Assistant Vice President, Investor Relations & Capital Markets

Richard brings 20 years of both corporate and consulting investor relations experience to LHS clients with vast industry experience including molecular diagnostics and other biotechnology companies.  Richard’s primary responsibilities include attracting new sell-side research and buy-side institutional ownership to each of LHS’s clients through participation in financial conferences, “non-deal” roadshows and other 1-on-1 meetings. Richard also leads LHS’s perception audit efforts and supports client companies throughout their quarterly earnings release processes.

Previous Experience
Senior consulting roles with investor relations firm, Gregory FCA

Director of Business Development at Discovery Investment Research and Executive Practice Leader at Kennedy Information
Led investor functions at Intelligroup, Inc. and Anadigics, Inc. and began his investor relations career as part of the team at Citigroup

Sample Client Representation (past and present)
Dipexium Pharmaceuticals
SIRION Biotech
Strongbridge Biopharma (formerly Cortendo AB)

Business development
Investor outreach and targeting
Shareholder identification
Perception Auditing
Client day to day representation on non-deal roadshows

Bachelor of Science, Accounting
Penn State University

Golf, basketball and traveling

New York Chapter, National Investor Relations Institute